Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...
Having helped the region raise multimillions in the last 12 months, Freeport East has pledged to generate more growth in 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback